{"id":"placebo-of-intravenous-l-citrulline","safety":{"commonSideEffects":[]},"_chembl":null,"_fixedAt":"2026-03-30T12:35:25.550122","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo serves as the control arm in phase 3 trials to establish the efficacy and safety of L-citrulline independent of non-specific effects. L-citrulline itself is a non-essential amino acid that acts as a nitric oxide precursor, enhancing endothelial function and vasodilation. The placebo arm allows researchers to isolate the true pharmacological benefit of L-citrulline from placebo response.","oneSentence":"This is a placebo control (inert substance) used in clinical trials to compare against active intravenous L-citrulline treatment.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:17.228Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"_fixedFields":["pubmed(5)"],"trialDetails":[{"nctId":"NCT06989567","phase":"PHASE3","title":"A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis","status":"NOT_YET_RECRUITING","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2025-07-25","conditions":"Sickle Cell Disease","enrollment":120},{"nctId":"NCT06635902","phase":"PHASE2","title":"Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease","status":"RECRUITING","sponsor":"Suvankar Majumdar","startDate":"2024-12-22","conditions":"Sickle Cell Disease, Vaso-occlusive Pain Episode","enrollment":99},{"nctId":"NCT05253209","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects","status":"TERMINATED","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2022-06-29","conditions":"Ventricular Septal Defect, Atrioventricular Septal Defect, Primum Atrial Septal Defect","enrollment":64},{"nctId":"NCT02891837","phase":"PHASE3","title":"L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects","status":"COMPLETED","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2016-08","conditions":"Acute Lung Injury","enrollment":189},{"nctId":"NCT04570384","phase":"PHASE2","title":"Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19","status":"COMPLETED","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2020-10-15","conditions":"Acute Hypoxemic Respiratory Failure","enrollment":65},{"nctId":"NCT01120964","phase":"PHASE1, PHASE2","title":"Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol","status":"COMPLETED","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2010-09","conditions":"Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect","enrollment":22},{"nctId":"NCT01386034","phase":"PHASE3","title":"Effects of Oral Citrulline on Protein Metabolism in Patients With Intestinal Failure (Citrugrêle 2)","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2012-07","conditions":"Intestinal Failure","enrollment":11},{"nctId":"NCT01474863","phase":"PHASE2","title":"Citrulline in Severe Sepsis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2012-08","conditions":"Severe Sepsis, Acute Lung Injury","enrollment":72},{"nctId":"NCT02772861","phase":"NA","title":"Citrulline Challenge Study for Healthy Subjects in the United Kingdom","status":"COMPLETED","sponsor":"University College, London","startDate":"2011-08","conditions":"Intestinal Diseases","enrollment":20},{"nctId":"NCT00335244","phase":"PHASE3","title":"Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery","status":"COMPLETED","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2006-05","conditions":"Heart Defects, Congenital, Hypertension, Pulmonary","enrollment":77},{"nctId":"NCT00756080","phase":"PHASE1","title":"\"Effects of Oral Citrulline on Protein Metabolism in Healthy Humans: a Prospective, Randomized, Double-blind , Cross-over Study\" (Citrugrêle)","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2008-09","conditions":"Healthy Subjects","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"recentPublications":[{"date":"2023 Apr","pmid":"36698745","title":"Design of an adaptive randomized clinical trial of intravenous citrulline for sickle cell pain crisis in the emergency department.","journal":"Contemporary clinical trials communications"},{"date":"2019 Dec","pmid":"30642738","title":"Effect of oral citrulline supplementation on whole body protein metabolism in adult patients with short bowel syndrome: A pilot, randomized, double-blind, cross-over study.","journal":"Clinical nutrition (Edinburgh, Scotland)"},{"date":"2003 May","pmid":"12771626","title":"Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia.","journal":"Critical care medicine"},{"date":"2002 Aug","pmid":"12215958","title":"L-arginine reduces exercise-induced increase in plasma lactate and ammonia.","journal":"International journal of sports medicine"},{"date":"1999 Jun","pmid":"10360855","title":"L-arginine infusion dilates coronary vasculature in patients undergoing coronary bypass surgery.","journal":"Anesthesiology"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of intravenous L-citrulline","genericName":"Placebo of intravenous L-citrulline","companyName":"Asklepion Pharmaceuticals, LLC","companyId":"asklepion-pharmaceuticals-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}